These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 12695156)
1. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Fiehn C; Hajjar Y; Mueller K; Waldherr R; Ho AD; Andrassy K Ann Rheum Dis; 2003 May; 62(5):435-9. PubMed ID: 12695156 [TBL] [Abstract][Full Text] [Related]
2. The current role for clinical and renal histological findings as predictor for outcome in Australian patients with lupus nephritis. Nossent J; Raymond W; Kang A; Wong D; Ognjenovic M; Chakera A Lupus; 2018 Oct; 27(11):1838-1846. PubMed ID: 30092734 [TBL] [Abstract][Full Text] [Related]
3. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases. Shen K; Yu Y; Tang Z; Liu Z; Li L Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and outcome analysis of adult lupus nephritis patients in China. Tang Y; Zhang X; Ji L; Mi X; Liu F; Yang L; Qin W Int Urol Nephrol; 2015 Mar; 47(3):513-20. PubMed ID: 25563231 [TBL] [Abstract][Full Text] [Related]
5. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil. Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341 [TBL] [Abstract][Full Text] [Related]
6. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851 [TBL] [Abstract][Full Text] [Related]
7. Recurrent lupus nephritis after transplantation: Clinicopathological evaluation with protocol biopsies. Çeltİk A; Şen S; Tamer AF; Yılmaz M; Sarsık B; Özkahya M; Başçı A; Töz H Nephrology (Carlton); 2016 Jul; 21(7):601-7. PubMed ID: 26482014 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive treatment of the glomerulonephritis of systemic lupus. Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis. Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566 [TBL] [Abstract][Full Text] [Related]
11. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis. Ayodele OE; Okpechi IG; Swanepoel CR Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862 [TBL] [Abstract][Full Text] [Related]
12. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome. Mitwalli AH; Hayat A; Alwakeel J; Hammad D Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749 [TBL] [Abstract][Full Text] [Related]
13. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis. Koo HS; Kim S; Chin HJ Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis. Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376 [TBL] [Abstract][Full Text] [Related]
15. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Moroni G; Vercelloni PG; Quaglini S; Gatto M; Gianfreda D; Sacchi L; Raffiotta F; Zen M; Costantini G; Urban ML; Pieruzzi F; Messa P; Vaglio A; Sinico RA; Doria A Ann Rheum Dis; 2018 Sep; 77(9):1318-1325. PubMed ID: 29730634 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of biopsy-proven lupus nephritis in Iran. Fatemi A; Kazemi M; Sayedbonakdar Z; Farajzadegan Z; Karimzadeh H; Moosavi M Int J Rheum Dis; 2013 Dec; 16(6):739-46. PubMed ID: 24267776 [TBL] [Abstract][Full Text] [Related]
17. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort. Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780 [TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Bogdanović R; Nikolić V; Pasić S; Dimitrijević J; Lipkovska-Marković J; Erić-Marinković J; Ognjanović M; Minić A; Stajić N Pediatr Nephrol; 2004 Jan; 19(1):36-44. PubMed ID: 14634858 [TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathological profile of lupus nephritis and response to treatment with cyclophosphamide: A single center study. Sharma M; Das HJ; Doley PK; Mahanta PJ Saudi J Kidney Dis Transpl; 2019; 30(2):501-507. PubMed ID: 31031386 [TBL] [Abstract][Full Text] [Related]
20. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis. Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]